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Introduction
Transbronchial lung cryobiopsy (TLCB) was first described 
in 2009 (1) and since then it has become a common 
diagnostic method in interventional pulmonology. Being a 
safe and cost-effective method, it has been used to diagnose 
interstitial lung diseases (ILDs) (2,3). It is estimated that 
its diagnostic yield varies from 75% to 91% (4-6) and it is 
superior to traditional transbronchial lung biopsy (TBLB) 
(6,7) in terms of effectiveness. Although not yet as effective 
as open lung biopsy, its efficacy and safety are unquestionable 
(8,9). Consequently, it becomes a good alternative to open 
lung biopsy (10) and is always the first recommended 
procedure (11). While several interstitial diseases have 
been diagnosed by histopathological analysis of cryobiopsy 
samples, there are no studies, which would refer to idiopathic 
pulmonary hemosiderosis (IPH) confirmed by this diagnostic 
method. Here, we present what we believe to be the first IPH 
case to be confirmed by TLCB. 
Case presentation
A 54-year-old man was admitted to the pulmonary medicine 
department for diagnostics of ILD. He reported a reduced 
ability to exercise for the last 3 years. Since a few months he 
noted grade 2 dyspnea according to the modified Medical 
Research Council scale. He additionally complained of 
coughing up sputum but denied hemoptysis. Five years 
earlier, the patient had an upper gastrointestinal tract 
bleeding due to a duodenal ulcer and gastritis resulting in 
anemia. He was further diagnosed with hiatal hernia with 
gastroesophageal reflux. He had not been smoking for 
12 years but he had a 25 pack-year smoking history.
A year earlier,  following abnormal chest X-ray 
findings (Figure 1), the patient had a high-resolution 
computed tomography (HRCT), which showed bilateral 
lung emphysema visible especially in upper lobes and 
coexisting interstitial fibrosis as well as broad interstitial 
opacities (Figure 2). He was then hospitalized at a regional 
pulmonology department where some preliminary tests 
were performed, including bronchoscopy, which did not 
show any abnormalities. In a 6-minute walk test (6-MWT) 
the patient walked 530 m with significant desaturation, but 
spirometry did not confirm any ventilation abnormalities. 
On admission to the pulmonary clinic, the patient was in a 
good condition without significant abnormalities on physical 
examination. His arterial blood oxygen saturation was 97% at 
room air. Laboratory tests showed mild leukocytosis with an 
increased neutrophil level as well as mild normocytic anemia 
with high reticulocyte count. Following a hematological 
consultation, the patient was diagnosed with sideropenic 
anemia and chronic disease anemia due to low blood iron 
level with concurrent high iron-binding and absorption 
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capability and high ferritin count.
The results of ANA, ANCA, anti-glomerular basement 
membrane antibodies tests as well as alpha-1 antitrypsin 
level and test showed no abnormalities. Chest HRCT 
showed clearly visible interstitial fibrosis. Lung function 
tests presented lowered CO diffusion capacity single breath 
transfer factor for carbon monoxide (DLCO SB) was 
47.6%) while spirometry and body plethysmography values 
were normal. In the 6-MWT the patient walked 589 m 
with significant desaturation. Echocardiography did not 
show any significant valvular defects and Doppler-measured 
systolic pulmonary artery pressure was 44 mmHg. Due 
to the abnormalities in HRCT imaging, the patient was 
suspected of having pulmonary Langerhans cell histiocytosis 
but bronchoalveolar lavage (BAL) immunohistochemical 
analysis of Langerhans cells was negative for S-100 protein 
and anti-CD1a antibodies. Unexpectedly, BAL showed the 
presence of hemosiderin-laden macrophages (74%) (Table 1). 
The patient was admitted for TLCB to an interventional 
bronchoscopy unit. A radial EBUS mini-probe was used 
to select the optimal site for biopsy and thus there was no 
fluoroscopy. Cryobiopsy samples were obtained from two 
segments of the middle lobe with a 1.9 mm probe (freezing 
time of 5–8 seconds). In total, there were 5 samples 
taken. Histopathological examination revealed numerous 
hemosiderophages (i.e., hemosiderin-laden macrophages) 
and erythrocytes within alveolar spaces, interalveolar septal 
thickening and fibrosis as well as alveolar pneumocyte 
hyperplasia. A delicate incrustation of some vascular walls 
by iron deposits was noted (Figure 3). There were no 
features of concurrent vasculitis. Thus an intra-alveolar 
hemorrhage was diagnosed.
The additional diagnostic tests shown in Table 2 were 
performed. Considering the result of the microscopic 
examination of the lung tissue and the broad panel of tests 
employed which did not show the origin of the intra-
Figure 1 Chest X-ray in PA projection. Lung lobes with broad 
dense parenchymal opacification and numerous small nodules. PA, 
posteroanterior.
Figure 2 HRCT lung scan. Bilateral emphysema, especially 
visible in the upper zones of each lung lobe; concurrent interstitial 
fibrosis as well as broad ground glass opacities in lung parenchyma. 
HRCT, high-resolution computed tomography.
Table 1 Results of bronchoalveolar lavage evaluation
Test type Result 
Total cell number 3,209
Cell concentration/mL 53,483
Macrophages (%) 74
Lymphocytes (%) 3
Neutrophils (%) 22
Eosinophils (%) 1
Epithelial cells (glandular and squamous) Insignificant number
Birefringent bodies Negative
CD1a Negative
S100 Negative
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alveolar bleeding, the final diagnosis of primary IPH was 
established.
Following the diagnosis, the patient was subsequently 
readmitted to the pulmonary clinic for treatment. On 
admission he was not in a good condition with no rest 
dyspnea but peripheral oxygen saturation was 90% at 
room air. Arterial blood gases showed mild hypoxemic 
respiratory failure (PaO2 =51 mmHg, PaCO2 =34 mmHg 
and pH=7.43). Initially, 32 mg/day methylprednisolone 
per os was introduced. On the third day of treatment, the 
patient became febrile and had moderate hemoptysis. 
Chest X-rays showed new lung infiltrates. The C-reactive 
protein (CRP) level was 210 mg/L. Flexible bronchoscopy 
revealed fresh bleeding into the bronchial tree. Klebsiella 
pneumoniae was cultivated at 106 CFU/mL. The patient was 
diagnosed with hospital acquired pneumonia and diffuse 
alveolar hemorrhage. Broad-spectrum antibiotic therapy 
was introduced along with oxygen therapy and 150 mg/day 
methylprednisolone administered intravenously. As the 
Figure 3 Microscopic images of pulmonary hemosiderosis. (A) Hemosiderin laden macrophages (cells with golden-brown pigment) filling 
alveolar spaces. Mild interstitial fibrosis with hyperplasia of type II pneumocytes lining the interalveolar septa; (B) hemosiderin globules 
stain intensively with Prussian blue; (C) iron encrustation of the elastic laminae of blood vessels can be observed as grey mineralized fibers in 
vessel walls; (D) the same fibers show intensively blue color in Prussian blue reaction (A: HE staining, magnification ×100; B and D: Prussian 
blue staining, magnification ×400; C: HE staining, magnification ×400). 
A
C
B
D
Table 2 Tests performed to diagnose the origin of intra-alveolar 
bleeding 
Test type Result
ANA Negative
ANCA Negative
Rheumatoid factor Negative
Lupus anticoagulant Negative
Endomysial antibodies IgA Negative
Glomerular basement membrane GBM Negative
IgA and IgG (tTG) antibodies Negative
Anti-CCP antibodies Negative 
IgG anti-cardiolipin antibodies Negative
IgM anti-cardiolipin antibodies Negative
Beta 2 glycoprotein 1 antibodies IgG Negative
Negative migrating immunological 
complexes (Caq-CIC)
Negative
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patient’s condition stabilized after a few days of treatment, 
azathioprine 150 mg/d was introduced. Methylprednisolone 
doses were then gradually reduced. After the patient’s 
condition improved and inflammation regressed, control 
lung function tests were performed: TLCO SB was at a 
low but stable level (39%) and in the 6-MWT the patient 
walked 627 m without significant desaturation.
A z a t h i o p r i n e  1 5 0  m g / d  w a s  c o n t i n u e d  a n d 
methylprednisolone was gradually reduced (20 mg/day at 
present). After discharge he was referred for a transplant 
consultation but was disqualified due to the high risk of 
relapse observed in IPH patients (12). In the first three 
months of treatment, the patient reported a significant 
clinical improvement and he felt even better in the 
following months. Presently, the patient’s peripheral oxygen 
saturation at air room is 93% and he does not require long-
term oxygen therapy.
In order to broaden the discussion of this case we invited 
3 experts from different fields of medicine to participate in 
the case discussion and answer our questions. 
Discussion
Question 1: What is the main advantage of cryobiopsy over 
the conventional forceps one?
Expert 1 (Antonio Bugalho, expert in interventional 
pulmonology) 
Transbronchial lung cryobiopsy (TBLC) can improve 
the diagnostic yield in diffuse parenchymal lung diseases 
especially when clinical and radiological data is insufficient 
to establish a definitive diagnosis, as in the present case. 
Current evidence shows that performing two transbronchial 
lung cryobiopsies from two different segments within the 
same lobe increases diagnostic yield in diffuse parenchymal 
lung diseases, nevertheless most centers usually perform 
3 to 5 biopsies. 
In this case, a 1.9 mm probe was used through the 
flexible bronchoscope working channel. Commonly, with 
this cryoprobe, a freezing time of 7 seconds is sufficient to 
get a good tissue sample but the duration should be adjusted 
according to the obtained sample size. A radial ultrasound 
probe was previously used to identify the aimed lung 
parenchyma and to exclude adjacent blood vessels. 
The correct selection of patients is crucial in order to 
provide an effective diagnosis and diminish complications. 
This patient had no severe pulmonary hypertension (as 
defined by a pulmonary arterial pressure of >50 mmHg), 
forced vital capacity (FVC) <50% or DLCO <35% which 
are considered relative contraindications for TBLC.
It is a very important point that cryobiopsies have 
been performed heterogeneously with different strategies 
regarding the procedure (intubation methods, sedation/
anesthesia, probe sizes, freezing time), lung tissue sampling 
(number of samples, one or multiple lobes, distance to 
the pleura) and complications (rates, methods to control). 
Thus, systematization of knowledge in this respect as 
well as standardization are needed. The TBLB technique 
is definitely more systematized. However, considering 
the efficacy of TBLC in the diagnosis of interstitial lung 
diseases, it is advisable to use this method when TBLB 
proves insufficient or even as a primary method because it 
can provide pathologists with considerably better samples 
for microscope examination. 
Expert 2 (Martina Vašáková, clinical expert)
For clinicians, the efficacy and safety of a diagnostic method 
are of key importance. Sharp’s meta-analysis of 11 studies 
on TBLB, 11 on TBLC and 24 on surgical lung biopsy 
(SLB) revealed a diagnostic yield of 64.3%, 84.4% and 
91.1% respectively (6). Furthermore, the recent meta-
analysis by Iftikhar, comparing TBLC with SLB, showed 
that diagnostic accuracy of TBLC is comparable with SLB 
with an acceptable safety profile (9). While we should never 
forget about individual clinical context, we may agree that 
TBLC is often the optimal diagnostic method for interstitial 
lung diseases. 
The case describes an ex-smoker with shortness of 
breath, anemia and dominant emphysema with some 
interstitial changes at HRCT. Initially, the diagnosis of 
pulmonary Langerhans cell histiocytosis (PLCH) was 
suspected, but since the BALF proved inconclusive further 
diagnostics had to be undertaken. Following the cryobiopsy, 
the patient was diagnosed with idiopathic pulmonary 
hemosiderosis (IPH). The CT scan resembles rather that 
of emphysema or inactive PLCH, since emphysema is not 
typical for IPH. If it was not for the cryobiopsy performed, 
the patient would have been misdiagnosed with PLCH. 
Expert 3 (Anja C. Roden, specialist in 
pathomorphology)
The images of this case illustrate and support the advantages 
of cryobiopsies over conventional forceps biopsies that in 
general include larger specimen size and well expanded 
alveoli allowing for easier histologic interpretation.
The cryobiopsy samples show a large piece of lung 
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parenchyma with no crush artifact. I agree that the 
morphologic findings of large intra-alveolar clusters of 
hemosiderophages and iron-encrustation of elastic laminas 
of vessels suggestive of mineralizing pulmonary elastosis are 
typical for pulmonary hemorrhage. Reportedly, extensive 
clinical and serologic workup was essentially negative 
except for a suggestion of pulmonary hypertension given a 
pulmonary artery pressure of 44 mmHg. There are only a 
few causes of alveolar hemorrhage that might be recognized 
morphologically; these include necrotizing vasculitis, 
pulmonary veno-occlusive disease (PVOD), possibly 
aspiration, infection, or neoplasms such as angiosarcoma. 
No morphologic features in this cryobiopsy are suggestive of 
any of these potential causes. There is some mild interstitial 
thickening which appears to be due, at least in part, to a mild 
capillary proliferation, however, the typical morphological 
features of PVOD such as more pronounced patchy capillary 
proliferation together with intimal fibrosis of small veins 
and venules leading at least focally to their occlusion is not 
appreciated in this specimen. An elastic stain would be helpful 
to further exclude that possibility. However, many causes 
of pulmonary hemorrhage have no morphologic correlate 
and require clinico-radiologic correlation which is necessary 
before a diagnosis of idiopathic pulmonary hemorrhage can 
be rendered. It also remains unclear why this patient has 
pulmonary hypertension.
Question 2: How do you assess the efficacy of cryobiopsy in 
the diagnostics of IPH on the basis of this case?
Expert 1 (Antonio Bugalho)
I emphasize that TBLC should always be part of a 
multidisciplinary approach to diffuse lung diseases. When 
performed by trained professionals in an adequate setting, 
it may be able to provide good quality histological material 
that contributes to IPH diagnosis. 
Expert 2 (Martina Vašáková)
The case discussed here proves how important cryobiopsy 
can be for IPH diagnosis. However, cryobiopsy alone should 
not be considered sufficient because it must be admitted that 
diagnosis of IPH is per exclusionem and thus it needs to exclude 
other causes of hemorrhage, mainly vasculitis, antiphospholipid 
syndrome and anti-basement membrane disease. 
Expert 3 (Anja C. Roden)
Histopathological images are not sufficient to diagnose IPH 
but the information obtained by a pathologist thanks to 
TBLC can be extremely useful in the differential diagnosis 
of intra-alveolar hemorrhages and in the final clinical 
diagnosis. 
Conclusions 
Idiopathic pulmonary hemosiderosis is a rare disease, 
which is a result of an alveolar capillary bleeding and it is 
characterized by a high mortality rate (13,14). The disease 
is extremely rare in adults (15-18). The clinical course 
usually suggests intra-alveolar bleeding with characteristic 
hemoptysis (19) observed in about 80% of patients 
(15,17,18). In cases similar to the present one, i.e., where 
there are lung interstitial alterations with a concurrent 
anemia, IPH should always be considered in the differential 
diagnosis even though hemoptysis might not be reported 
by the patient (14,17,19-22). The disease is usually found 
in children and young adults and thus lung interstitial 
alterations appear amid a healthy lung tissue. However in 
adults, comorbidities are more frequently present, also in 
the case of the respiratory system. Our patient, a former 
smoker, had pulmonary emphysema further aggravated by 
concurrent IPH. Consequently, his lung HRCT imaging 
was equivocal. Flexible bronchoscopy with BAL can also 
be helpful in diagnostics (15). Apart from newly found 
bleeding, proof of chronic intra-alveolar bleeding in the 
form of hemosiderin-laden macrophages is necessary for 
establishing the diagnosis and this feature has also been 
found in our patient. 
It is known that the progression of idiopathic pulmonary 
hemosiderosis can be gradual but in some cases the disease 
can relapse resulting in sudden intra-alveolar bleeding. The 
risk factors for relapses are not known as such relapses are 
often spontaneous. However, it seems that in the case of 
our patient respiratory tract infection could be an important 
risk factor (16). This is a life-threatening condition and 
should be treated immediately. Although the use of steroids 
in such a situation has been questioned (23), the benefits 
of this therapy cannot be ignored (24). Steroids were 
applied in the present case and led to clinical improvement 
of the patient’s condition. Since general practice in 
severe exacerbations of ILDs is to use steroids with other 
immunosuppressants, the same has been applied in the 
present case. Azathioprine allowed to reduce gradually the 
doses of methylprednisolone. Mesenchymal stem cells (25) 
can also be used as an additional therapy option. As we had 
no experience in applying this method, we did not offer it to 
the patient. 
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To our best knowledge, there are no case studies on 
primary IPH diagnosed with TLCB but we observe a 
growing number of publications describing the usefulness of 
TLCB based on samples obtained in cryobiopsies (26). This 
method can be used in cases of interstitial lung diseases, e.g., 
idiopathic pulmonary fibrosis, to secure diagnostic material 
for microscopic examination of ILDs when traditional TBLB 
is usually inadequate, like in IPF (27). The clinical usefulness 
of TLCB in other ILDs which have been diagnosed 
previously with open lung biopsy has also already been 
described in other studies (5). We may thus further confirm 
the hypothesis that TLCB can be considered an effective 
method for obtaining a sample suitable for histopathological 
examination of other rare diseases such as IPH. 
In the present case TLCB was uncomplicated and 
hence, when IPH is suspected, it could be considered as 
the method of choice before an open lung biopsy. When 
determining whether to perform TLCB from one or two 
lung segments, it should be remembered that the latter is 
more effective (28). Bearing that in mind, we also decided 
for cryobiopsy from two segments of the middle lobe. 
TBLC is a very valuable method for the diagnosis of IPH 
and, according to the experts bronchoscopy specialist, its 
use should be recommended because it is safe and effective. 
It also provides sufficient samples for the pathologist 
and finally allows the clinical specialist to make a correct 
diagnosis. Although prognoses are uncertain for IPH, 
immunosuppressive treatment is a good chance to achieve a 
stable patient’s condition.
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